• Search
  • Login
  • Register
Menu
  • Last issue
  • Home
  • News
  • CongressUpdate
  • Specials
  • Guidelines
  • Links
All
  • All
  • BJMO articles
  • Blog articles
  • Specials
Forgot Password? Not a member yet? Register here
News > Clinical Practice

Category

All
  • Pharma News
  • Health of Tomorrow
  • Opinion
  • Art Corner
  • Fundraising
  • Prevention
  • Science
  • Clinical Practice
  • Corona
  • Cancer trials
  • Healthy Living
  • Medical Research
  • Art on View
  • Viewpoints
  • Therapy
  • Health Innovation
  • Podcasts
  • Editor's pick
  • Special
  • BSMO Meeting 2021
  • Covid-19
  • EADO 2021
  • Society Announcement

Clinical Practice

Balancing the risks and benefits of adjuvant systemic treatments in low-risk ER+/HER2- breast ...

Read more
subscribe Latest issue All issues Newsletters
Index latest issue
  • INTRODUCTION
  • Emerging therapies in gynaecological cancers (part 1) : Locally advanced and metastatic cervical cancer
  • Clinical application of circulating tumour DNA (ctDNA) in breast cancer management
  • Support for bowel problems after rectal cancer during a nursing consultation
  • “Right to be forgotten” (RTBF) for cancer survivors: The Belgium situation
  • Highlights of the Gastrointestinal Cancers Symposium 2025
  • SABCS 2024: Highlights of new data on systemic therapy for breast cancer
  • New oncology reimbursements in Belgium
Clinical Practice

Overdiagnosis of breast cancer estimation in the US: one in seven screen-detected cases

Read more
Clinical Practice

The KEYNOTE-811 trial evaluating dual PD-1 and HER2 blockade in HER2-positive gastric cancer

Read more
Clinical Practice

Combination of relatlimab and nivolumab improves PFS in advanced melanoma

Read more
Clinical Practice

Better clinical outcomes with Immune checkpoint inhibitors than the standard of care for unres...

Read more
Clinical Practice

Female melanoma patients show limited benefits from immunotherapy

Read more
Clinical Practice

No additional benefit with intensive surveillance in relapsed rhabdomyosarcoma

Read more
Clinical Practice

Diagnostic urine test identifies ‘intermediate risk’ prostate cancer patients

Read more
Clinical Practice

Rapid Increase in the use of CDK4/6 inhibitors as treatment for HR+/HER2- advanced breast canc...

Read more
Previous 1 2 3 4 5 6 7 Next
Top

Join our newsletter

  • This field is for validation purposes and should be left unchanged.
  • About BJMO
  • Ads & sponsoring
  • Vacancies
  • Disclaimer
  • Privacy
  • Contact

BJMO is published by Ariez International BV, Westzijde 22, 1506 EE Zaandam, The Netherlands

© BJMO 2025

Manage Cookie Consent

To provide the best experiences, we and our partners use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us and our partners to process personal data such as browsing behavior or unique IDs on this site and show (non-) personalized ads. Not consenting or withdrawing consent, may adversely affect certain features and functions.

Click below to consent to the above or make granular choices. Your choices will be applied to this site only. You can change your settings at any time, including withdrawing your consent, by using the toggles on the Cookie Policy, or by clicking on the manage consent button at the bottom of the screen.

Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Statistics

Marketing

Features
Always active

Always active
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}